XML 48 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Incentive Plans
9 Months Ended
Sep. 30, 2012
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 7 – Equity Incentive Plans

 

General

 

DCT’s share-based awards are long-term retention plans that are intended to attract, retain and provide incentives for talented employees. DCT believes its share-based awards are critical to its operation and productivity. The employee share-based award plans allow DCT to grant, on a discretionary basis, incentive stock options and non-qualified stock options.

 

The following table sets forth, by the respective option plan, certain aspects of DCT’s stock options as of September 30, 2012:

 

Option Approval Method Options Outstanding and Options Available
Description Board of
Directors
Board of
Directors
and
Shareholders
Total Outstanding Available
For
Future
Grant
Total
2002 Amended and Restated Stock Option Plan 3,200,000 3,200,000 2,753,710 446,290 3,200,000
2006 Stock Option Plan 2,500,000 2,500,000 2,149,000 351,000 2,500,000
2009 Stock Option Plan 1,500,000 1,500,000 1,179,333 320,667 1,500,000
2010 Stock Option Plan 3,500,000 3,500,000 2,500,000 1,000,000 3,500,000
Key Personnel Option Grants 7,875,000 7,875,000 4,518,465 4,518,465
7,875,000 10,700,000 18,575,000 13,100,508 2,117,957 15,218,465

 

Stock Options

 

DCT issues options under four different stock option plans as well as through employment agreements with key employees, executives and consultants (approved by the board of directors on a case-by-case basis). Options generally vest over two to three years from the date of grant and expire seven to ten years from the date of grant.

 

Stock-Based Compensation

 

The following table sets forth the total stock-based compensation expense included in DCT’s Statements of Operations (in thousands):

Three Months Ended
September 30,
Nine Months Ended
September 30,
2012 2011 2012 2011
Selling, general and administrative $ 206 $ 302 $ 674 $ 886
Research and development 18 23 53 85
Total $ 224 $ 325 $ 727 $ 971

 

At September 30, 2012, DCT had approximately $322,000 of total unrecognized compensation cost related to unvested stock options. This cost is expected to be recognized over a weighted-average period of approximately one year.

 

Stock Option Activity and Outstanding

 

DCT had the following stock option activity during the nine months ended September 30, 2012:

 

Options Weighted-
Average
Exercise
Price
Outstanding at December 31, 2011 14,524,358 $ 0.34
Granted 275,000 0.35
Exercised (1,498,850 ) (0.01 )
Canceled (200,000 ) (0.32 )
Outstanding at September 30, 2012 13,100,508 $ 0.38

 

In April 2012, DCT’s Board of Director’s approved a one-year extension to 643,465 options. The incremental fair value of the amended options, as calculated using the Black-Scholes valuation model, was $2,000 and was recorded as operating expense with the offsetting credit to additional paid-in capital during the second quarter of 2012.

 

The following table summarizes all options outstanding and exercisable by price range as of September 30, 2012:

 

Options Outstanding Options Exercisable
Range of
Exercise Prices
Number
Outstanding
Weighted-
Average
Remaining
Contractual
Life (Years)
Weighted-
Average
Exercise
Price
Number
Exercisable
Weighted-
Average
Exercise
Price
$0.01 643,465 0.6 $ 0.01 643,465 $ 0.01
$0.29-$0.45 9,557,043 5.5 0.32 7,225,075 0.31
$0.60 - $0.70 2,900,000 6.1 0.68 2,200,000 0.68
13,100,508 10,068,540

 

The “intrinsic value” of options is the excess of the value of DCT stock over the exercise price of such options. The total intrinsic value of options outstanding (of which all are expected to vest) was approximately $129,000 and $1,546,000 at September 30, 2012 and December 31, 2011, respectively. The total intrinsic value for exercisable options was $129,000 and $1,303,000 at September 30, 2012 and December 31, 2011, respectively. The total intrinsic value was $475,000 for options exercised during the nine months ended September 30, 2012. The total intrinsic value was $43,000 for options exercised during the nine months ended September 30, 2011.